Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Classifica tra le azioni #39567
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Prezzo delle azioni
$0.003084
Capitalizzazione di mercato
$434.03K
Variazione (1 giorno)
-7.14%
Variazione (1 anno)
-89.24%
Paese
BE
Scambia Oxurion N.V. (OXUR)

Categoria

Storico del prezzo dell'azione per Oxurion N.V. (OXUR)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $62.97K il 2006-07-01
Storico del prezzo dell'azione di Oxurion N.V. dal 2006 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$517.18 32.51%
US
$857.76 31.47%
NL
$737.68 8.00%
CH
$1.07K -6.40%
KR
$258.82 14.34%
BE